Metabolic factors accelerate colorectal adenoma recurrence

BMC Gastroenterology

Volumn 14, Issue 1, 2014, Pages

  Taniguchi, Leo ^a   Higurashi, Takuma ^b   Uchiyama, Takashi ^a   Kondo, Yoshinobu ^a   Uchida, Eri ^e   Uchiyama, Shiori ^c   Jono, Fumitake ^d   Hamanaka, Jun ^f   Kuriyama, Hitoshi ^a   Hata, Yasuo ^a   Endo, Hiroki ^b   Takahashi, Hirokazu ^b   Nagase, Hajime ^c   Matsuhashi, Nobuyuki ^f   Nakajima, Atsushi ^b  

^a CHIGASAKI MUNICIPAL HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c YOKOHAMA ROSAI HOSPITAL   (Japan)

^d TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^e Machida Municipal Hospital   (Japan)

^f Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

Author keywords

Colorectal adenoma recurrence; Metabolic factor

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; COLONOSCOPY; COLORECTAL ADENOMA; DYSPLASIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTESTINE VILLUS; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLISM; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE RISK; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; TUMOR VOLUME; ADENOMA; CLINICAL TRIAL; COLORECTAL TUMOR; INTRAABDOMINAL FAT; MULTICENTER STUDY; PATHOLOGY; RISK FACTOR;

ADENOMA; AGE FACTORS; AGED; BLOOD GLUCOSE; BODY MASS INDEX; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84964312674     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-14-187     Document Type: Article

References (26)

1. Siegel R, Desantis C, Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin 2014, 64(2):104-117.
2. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR: Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012, 143(3):844-857.
3. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD: Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012, 366(8):687-696.
4. Limburg PJ, Anderson KE, Johnson TW, Jacobs DR Jr, Lazovich D, Hong CP, Nicodemus KK, Folsom AR: Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005, 14(1):133-137.
5. Elwing JE, Gao F, Davidson NO, Early DS: Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am J Gastroenterol 2006, 101(8):1866-1871.
6. Otani T, Iwasaki M, Ikeda S, Kozu T, Saito H, Mutoh M, Wakabayashi K, Tsugane S: Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees (Japan). Cancer Causes Control 2006, 17(10):1245-1252.
7. Liu CS, Hsu HS, Li CI, Jan CI, Li TC, Lin WY, Lin T, Chen YC, Lee CC, Lin CC: Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol 2010, 10:51.
8. Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO, Park SS, Yang S, Son HJ, Rhee PL, Kim JJ, Rhee JC, Choi YH: Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 2007, 16(8):1543-1546.
9. Orannapalai N, Attawettayanon W, Kanngern S, Boonpipattanapong T, Sangkhathat S: Predicting the occurrence of cancer-associated colorectal polyp using a metabolic risk score. Mol Clin Oncol 2013, 2(1):124-128.
10. Giovannucci E, Michaud D: The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007, 132(6):2208-2225.
11. Paggi S, Rondonotti E, Amato A, Terruzzi V, Imperiali G, Mandelli G, Terreni N, Lenoci N, Spinzi G, Radaelli F: Resect and discard strategy in clinical practice: a prospective cohort study. Endoscopy 2012, 44(10):899-904.
12. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ: AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the obesity society. J Am Coll Cardiol 2013, 63(25 Pt B):2985-3023.
13. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome: Definition and the diagnostic standard for metabolic syndrome [in Japanese]. Nippon Naika Gakkai Zasshi 2005, 94:794-809.
14. [squared times]: Executive summary: standards of medical care in diabetes-2014. Diabetes Care 2014, 37(Suppl 1):S5-S13. doi: 10.2337/dc14-S005.
15. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K: Diabetes mellitus: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version. J Atheroscler Thromb 2014, 21(2):93-98.
16. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L: Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007, 132(1):96-102.
17. Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, Schnell TG, Chejfec G, Campbell DR, Kidao J, Bond JH, Nelson DB, Triadafilopoulos G, Ramirez FC, Collins JF, Johnston TK, McQuaid KR, Garewal H, Sampliner RE, Esquivel R, Robertson D: Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007, 133(4):1077-1085.
18. Yamaji Y, Mitsushima T, Ikuma H, Watabe H, Okamoto M, Kawabe T, Wada R, Doi H, Omata M: Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese. Gut 2004, 53(4):568-572.
19. Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG: Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997, 112(1):24-28.
20. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, Wong RK, Nugent PA, Mysliwiec PA, Schindler WR: Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003, 349(23):2191-2200.
21. Giorgino F, Laviola L, Eriksson JW: Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 2005, 183(1):13-30.
22. Cowey S, Hardy RW: The metabolic syndrome: a high-risk state for cancer? Am J Pathol 2006, 169(5):1505-1522.
23. Trayhurn P, Beattie JH: Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001, 60(3):329-339.
24. Chiu HM, Lin JT, Shun CT, Liang JT, Lee YC, Huang SP, Wu MS: Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol 2007, 5(2):221-229. quiz 141.
25. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN: The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010, 139(4):1128-1137.
26. Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME, Campbell H, Dunlop MG: Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 2010, 59(12):1670-1679.